XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - ValueSet, Authority Hl7

17,881 resources

By Version

R2: 0
R2B: 0
R3: 631
R4: 13,619
R4B: 220
R5: 3,383
R6: 28

By Realm

none: 802
au: 53
be: 108
ca: 49
ch: 389
cl: 150
cr: 11
cz: 48
de: 50
dk: 21
ee: 55
eu: 308
fi: 4
fr: 38
it: 92
nl: 402
no: 6
nz: 17
pl: 23
se: 10
us: 11,158
uv: 4,022
vn: 23
other: 5

Start Prev Rows 400 - 600 Next

Package	Version	Identity	Name/Title	Status	Date	Realm
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.246	Blood Transfusion	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.247	Conversion of Cardiac Rhythm	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.248	Conversion of Cardiac Rhythm	active	2021-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.249	Hysterectomy	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.250	Hysterectomy	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.251	Tracheostomy	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.252	Tracheostomy	active	2021-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.253	Ventilation	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.254	Ventilation	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.255	Severe Maternal Morbidity Diagnoses	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.256	Severe Maternal Morbidity Procedures	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.267	Gestational Diabetes	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.269	Gestational Diabetes	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.271	HIV in Pregnancy Childbirth and Puerperium	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.272	HIV in Pregnancy Childbirth and Puerperium	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.274	Preexisting Diabetes	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.275	Preexisting Diabetes	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.277	Previous Cesarean	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.278	Previous Cesarean	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.279	Pulmonary Hypertension	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.281	Pulmonary Hypertension	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.282	Multiple Pregnancy	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.284	Multiple Pregnancy	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.286	Bleeding Disorder	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.287	Bleeding Disorder	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.289	Morbid or Severe Obesity	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.290	Morbid or Severe Obesity	active	2022-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.291	Economic Housing Instability	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.292	Economic Housing Instability	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.295	Thyrotoxicosis	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.296	Thyrotoxicosis	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.297	Preterm Birth	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.299	Preterm Birth	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.300	Placenta Accreta	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.302	Placenta Accreta	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.303	Placental Abruption	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.305	Placental Abruption	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.306	Neuromuscular Disease	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.308	Neuromuscular Disease	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.309	Autoimmune Disease	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.311	Autoimmune Disease	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.312	Mental Health Disorder	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.314	Mental Health Disorder	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.315	Bariatric Surgery	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.317	Bariatric Surgery	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.318	Substance Abuse	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.320	Substance Abuse	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.321	Anemia	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.323	Anemia	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.324	Severe Preeclampsia	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.326	Mild or Moderate Preeclampsia	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.327	Severe Preeclampsia	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.329	Mild or Moderate Preeclampsia	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.330	Hypertension	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.332	Hypertension	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.333	Renal Disease	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.335	Renal Disease	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.336	Gastrointestinal Disease	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.338	Gastrointestinal Disease	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.339	Cardiac Disease	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.341	Cardiac Disease	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.344	Aortic Aneurysm	active	2025-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.357	Conversion of Cardiac Rhythm	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.358	Hysterectomy	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.359	Tracheostomy	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.360	Ventilation	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.361	Venous Thromboembolism in Pregnancy	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.363	Venous Thromboembolism in Pregnancy	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.364	Long Term Anticoagulant Use	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.366	Long Term Anticoagulant Use	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.368	Preadmission Observation Undelivered Mother	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.369	ED Visit and OB Triage	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.370	Present on Admission is No or Unable To Determine	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.371	COVID 19 Confirmed	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.372	COVID 19 Confirmed	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.373	COVID 19 Confirmed	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.374	Respiratory Conditions Related to COVID 19	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.375	Respiratory Conditions Related to COVID 19	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.376	Respiratory Conditions Related to COVID 19	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.377	Respiratory Support Procedures	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.378	Respiratory Support Procedures	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.379	Respiratory Support Procedures Related to COVID 19	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.387	Placenta Increta or Percreta	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.388	Placenta Increta or Percreta	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.10	Non essential Hypertension SNOMEDCT	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.12	Cirrhosis ICD10CM	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.151	Polycystic Ovary Syndrome	active	2023-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.16	Low Intensity Statin Therapy/Branded	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.17	Moderate Intensity Statin Therapy/Branded	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.18	High Intensity Statin Therapy/Branded	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.233	All Results of High Risk HPV Test	active	2023-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.234	High Risk HPV Positive Results	active	2023-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.263	High Risk Positive HPV Results Without HPV16 or HPV18	active	2023-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.268	HPV Negative Results	active	2023-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.27	Non pharmacologic treatments for chronic pain ICD10PCS	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.29	Non pharmacologic treatments for chronic pain SCT	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.298	Cervical Cytology Test	active	2023-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.299	HPV 16 Tests	active	2023-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.300	HPV 18 Tests	active	2023-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.305	Counseling for Physical Activity CPT	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.306	Counseling for Physical Activity ICD10CM	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.307	Counseling for Physical Activity CDS	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.322	Test 123	active	2025-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.34	Opioid pain medications	active	2023-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.36	Non pharmacologic treatments for chronic pain	active	2023-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.40	Suicide attempt	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.42	Naloxone and Nalmefene medications	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.43	Benzodiazepine medications	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.44	Stool softeners and laxatives	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.47	Anxiety	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.48	Anxiety	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.50	Sleep disordered breathing	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.51	Sleep disordered breathing	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.52	Anxiety	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.53	Sleep disordered breathing	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.54	Adjuvant pain medications	active	2023-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.6	Non essential Hypertension ICD9CM	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.7	Non essential Hypertension ICD10CM	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.79	Behavioral Counseling for Nutrition and Activity Referral	active	2023-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.85	Impaired Glucose Tolerance	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.87	Fasting Plasma Glucose	active	2023-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.88	Waist Circumference	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.9	Hypertension	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.92	First Degree Family Member	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.94	Glucose Tolerance Test Results	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.555	Patient Declines Treatment for Cluster Headache (SNOMEDCT)	active	2025-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.558	Acute Cluster Headache Medication (RXNORM)	active	2025-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.559	Long Term Preventive Medication for Cluster Headache	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.569	Migraine Preventive Medication	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.601	Acute Migraine Attack Medication	active	2025-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.605	NSAID OTC Migraine Attack Medication	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.606	NSAID Prescribable Migraine Attack Medication	active	2025-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.641	Neuromodulation for migraine	active	2023-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.642	No pain with headache	active	2023-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.643	Antiplatelets	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.644	Anticoagulants	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.645	Statin Medications	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.646	Anxiety Disorders (ICD10 and SNOMED)	active	2023-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.648	Depression Diagnosis (ICD10 and SNOMED)	active	2023-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.649	Psychosis (ICD10 and SNOMED)	active	2023-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.650	Cluster Headache (SNOMED)	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.651	Galcanezumab (RxNorm)	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.652	Lithium (RxNorm)	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.653	Verapamil	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.654	Long term preventive medications for cluster headache	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.655	Short term preventive medication for cluster headache	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.656	Zolmitriptan	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.657	Sumatriptan	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.658	Dihydroergotamine	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.659	Acute cluster headache medication	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.660	Acute cluster headache treatment	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.661	Short term preventive treatment for cluster headache	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.662	Long term preventive treatment for cluster headache	active	2023-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.663	Migraine diagnosis (ICD)	active	2025-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.664	Prescribable NSAIDs and Acute Migraine Attack Medication	active	2025-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.103	Abnormal Presentation	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.105	Abnormal Presentation	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.130	Respiratory Rate	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.15	Intravenous Thrombolytic tPA Therapy	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.16	Intraarterial Thrombolytic tPA Therapy	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.163	Systolic Blood Pressure	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.171	Abnormal Presentation	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.173	Delivery of Singleton	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.21	Intravenous or Intraarterial Thrombolytic tPA Therapy	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.26	Estimated Gestational Age at Delivery	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.27	Cornual Ectopic Pregnancy	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.38	General Or Neuraxial Anesthesia	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.39	Low Dose Unfractionated Heparin for VTE Prophylaxis	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.41	Glycoprotein IIb IIIa Inhibitors	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.55	Oxytocin	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.56	Dinoprostone	active	2025-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.58	Delivery Procedures	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.59	Delivery Procedures	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.67	PCI	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.68	Endotracheal Intubation	active	2018-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.69	Endotracheal Intubation	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.98	Delivery of Singleton	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.99	Delivery of Singleton	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.225	Opioid Medication Assisted Treatment (MAT) SNOMED	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.241	Schedule II, III and IV Opioid Medications	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.242	Opioid Use Disorder	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.243	Opioid Use Disorder	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.265	Inpatient, Emergency, and Observation Locations	active	2022-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.269	Medications for Opioid Use Disorder (MOUD)	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.274	NHSN Inpatient Encounter Class Codes	active	2024-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.277	Emergency Department Location	active	2024-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.278	Emergency Department Treatment Location	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.283	Emergency Department Location	active	2024-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.284	Emergency Department Location	active	2024-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.285	Mental Health Diagnosis without Substance Use Disorders	active	2024-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.286	Decision to Transfer	active	2024-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.35	Healthcare Agent or Proxy Choices	active	2022-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.10	Breastfeeding	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.100	Familial Hypercholesterolemia	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.102	Rhabdomyolysis	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.107	Low Intensity Statin Therapy	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.12	Liver Disease	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.13	Rhabdomyolysis	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.19	Atherosclerosis and Peripheral Arterial Disease	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.20	Atherosclerosis and Peripheral Arterial Disease	active	2025-02	us